Drugs / ISCOMATRIX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00464334 | Mar 2007 → Jan 2012 | Alzheimer disease | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01477580 Background | Jul 2012 → Jan 2014 | dengue disease | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ISCOMATRIX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00464334 ↗ |